Jason A Keyes
CIK 1678152 · Chief Financial Officer · last filed 2026-05-22
Jason A Keyes is a Chief Financial Officer who has filed 46 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for ACTU, was dated May 22, 2026. Across all open-market trades the lifetime net is −$384.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $293.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$293.8K
4
46
-$384.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACTU | Director | — | $1.06 | — | $0 | 3 | 2026-05-22 |
| EQ | Chief Financial Officer | 126,633 | $2.32 | $293.8K | -$384.0K | 30 | 2025-02-19 |
| Carisma Therapeutics Inc. (SESN) Delisted | Director | 2,000 | $12.58 | $25.2K | $0 | 4 | 2022-06-24 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | EVP, Chief Financial Officer | 3,031 | — | — | $0 | 5 | 2017-10-17 |
Recent Filings
46 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | ACTU | Grant (A) | — | $0 | EDGAR |
| 2025-07-08 | EQ | Notice (144) | −88,913 | -$28.5K | EDGAR |
| 2025-06-12 | EQ | Notice (144) | −10,000 | -$3.9K | EDGAR |
| 2025-05-23 | ACTU | Grant (A) | — | $0 | EDGAR |
| 2025-02-19 | EQ | Mixed | — | $0 | EDGAR |
| 2025-01-24 | EQ | Sell (S) | −10,000 | -$6.5K | EDGAR |
| 2025-01-06 | EQ | Grant (A) | +15,000 | $8.1K | EDGAR |
| 2024-11-15 | EQ | Sell (S) | −10,000 | -$7.0K | EDGAR |
| 2024-11-14 | EQ | Notice (144) | −20,000 | -$15.6K | EDGAR |
| 2024-09-27 | EQ | Sell (S) | −10,000 | -$8.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.